Financials

  • Market Capitalization 19.5066 B
  • Employee 7 200
  • Founded 1995
  • CEO Kevin Conroy
  • Website www.exactsciences.com
  • Headquarter Wisconsin, United States
  • FIGI BBG000CWL0F5
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-92.33
Price to sales ratio
5.9
Dividends per share
Dividend yield %

Exact Sciences Corporation

Exact Sciences Corporation is an American molecular diagnostics company based in Madison, Wisconsin, specializing in the detection of early-stage cancers. The company provides products for the detection and prevention of colorectal cancer, including Cologuard, the first stool DNA test for colorectal cancer, along with additional screening and precision oncological tests for other types of cancer. In November 2025, Abbott Laboratories agreed to acquire Exact Sciences in a deal worth roughly $21 billion.

新闻